Loading...

Envision Healthcare

BST:N16
Snowflake Description

Reasonable growth potential and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
N16
BST
$6B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The last earnings update was 65 days ago. More info.


Add to Portfolio Compare Print Invest
N16 Share Price and Events
Price Volatility
N16
Industry
5yr Volatility vs Market

Value

 Is Envision Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Envision Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Envision Healthcare.

BST:N16 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 13 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BST:N16
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 9.5%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.34
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.336 (1 + (1- 21%) (83.89%))
0.559
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.54% + (0.8 * 9.46%)
8.11%

Discounted Cash Flow Calculation for BST:N16 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Envision Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

BST:N16 DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (USD, Millions) 755.43 791.67 746.00 773.00 896.68
Source Analyst x4 Analyst x3 Analyst x1 Analyst x1 Est @ 16%, capped from 44.25%
Present Value
Discounted (@ 8.11%)
698.77 677.37 590.42 565.90 607.21
Present value of next 5 years cash flows $3,139.67
BST:N16 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= $896.68 × (1 + 0.54%) ÷ (8.11% – 0.54%)
$11,915.05
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= $11,915.05 ÷ (1 + 8.11%)5
$8,068.61
BST:N16 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= $3,139.67 + $8,068.61
$11,208.27
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $11,208.27 / 119.91
$79.97
BST:N16 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BST:N16 represents 0.85562x of NYSE:EVHC
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.85562x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 93.47 x 0.85562
€79.97
Value per share (EUR) From above. €79.97
Current discount Discount to share price of €39.35
= -1 x (€39.35 - €79.97) / €79.97
50.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Envision Healthcare is available for.
Intrinsic value
>50%
Share price is €39.35 vs Future cash flow value of €79.97
Current Discount Checks
For Envision Healthcare to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Envision Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Envision Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Envision Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Envision Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:N16 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in USD $-13.48
NYSE:EVHC Share Price ** NYSE (2018-10-10) in USD $45.99
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 29.95x
Germany Market PE Ratio Median Figure of 425 Publicly-Listed Companies 18.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Envision Healthcare.

BST:N16 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:EVHC Share Price ÷ EPS (both in USD)

= 45.99 ÷ -13.48

-3.41x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Envision Healthcare is loss making, we can't compare its value to the DE Healthcare industry average.
  • Envision Healthcare is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Envision Healthcare's expected growth come at a high price?
Raw Data
BST:N16 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.41x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 13 Analysts
142.2%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.79x
Germany Market PEG Ratio Median Figure of 274 Publicly-Listed Companies 1.43x

*Line of best fit is calculated by linear regression .

BST:N16 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= -3.41x ÷ 142.2%

-0.02x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Envision Healthcare is loss making, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Envision Healthcare's assets?
Raw Data
BST:N16 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in USD $38.57
NYSE:EVHC Share Price * NYSE (2018-10-10) in USD $45.99
Germany Healthcare Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Companies 1.5x
Germany Market PB Ratio Median Figure of 580 Publicly-Listed Companies 1.92x
BST:N16 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:EVHC Share Price ÷ Book Value per Share (both in USD)

= 45.99 ÷ 38.57

1.19x

* Primary Listing of Envision Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Envision Healthcare is good value based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess Envision Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Envision Healthcare has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Envision Healthcare expected to perform in the next 1 to 3 years based on estimates from 13 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
142.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Envision Healthcare expected to grow at an attractive rate?
  • Envision Healthcare's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Envision Healthcare's earnings growth is expected to exceed the Germany market average.
  • Envision Healthcare's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
BST:N16 Future Growth Rates Data Sources
Data Point Source Value (per year)
BST:N16 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 13 Analysts 142.2%
BST:N16 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 13 Analysts 7%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 7.2%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.1%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:N16 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 13 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:N16 Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31 9,752 849 3
2019-12-31 9,011 785 396 13
2018-12-31 8,443 805 -1,594 12
BST:N16 Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-06-30 8,144 443 -1,622
2018-03-31 8,018 737 266
2017-12-31 7,819 797 259
2017-09-30 7,009 630 -20
2017-06-30 5,840 604 -23
2017-03-31 4,652 436 -30
2016-12-31 3,498 420 -32
2016-09-30 3,010 462 174
2016-06-30 2,838 482 177
2016-03-31 2,721 521 165
2015-12-31 2,567 538 155
2015-09-30 2,444 564 116

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Envision Healthcare's earnings are expected to grow significantly at over 20% yearly.
  • Envision Healthcare's revenue is expected to grow by 7% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:N16 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 13 Analyst Estimates (S&P Global) See Below

All data from Envision Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:N16 Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31 3.72 3.72 3.72 1.00
2019-12-31 2.94 3.78 2.50 8.00
2018-12-31 -14.07 -13.19 -14.69 4.00
BST:N16 Past Financials Data
Date (Data in USD Millions) EPS *
2018-06-30 -13.48
2018-03-31 2.22
2017-12-31 2.19
2017-09-30 -0.19
2017-06-30 -0.26
2017-03-31 -0.40
2016-12-31 -0.54
2016-09-30 3.32
2016-06-30 3.47
2016-03-31 3.32
2015-12-31 3.22
2015-09-30 2.43

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Envision Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Envision Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Envision Healthcare has a total score of 4/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Envision Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Envision Healthcare's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Envision Healthcare does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Envision Healthcare's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Envision Healthcare's 1-year growth to the DE Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Envision Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Envision Healthcare Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:N16 Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 8,143.50 -1,622.30 287.60
2018-03-31 8,017.70 265.60 265.80
2017-12-31 7,819.30 259.40 255.80
2017-09-30 7,008.80 -20.20 183.50
2017-06-30 5,840.30 -23.20 157.50
2017-03-31 4,651.80 -29.60 145.80
2016-12-31 3,497.90 -31.70 125.90
2016-09-30 3,009.68 174.42 112.90
2016-06-30 2,837.71 177.12 93.70
2016-03-31 2,721.16 164.73 74.60
2015-12-31 2,566.90 154.90 105.80
2015-09-30 2,444.43 115.85
2015-06-30 2,296.56 65.07
2015-03-31 1,932.83 52.14
2014-12-31 1,621.90 50.50 29.30
2014-09-30 1,316.62 40.67
2014-06-30 1,077.31 67.08
2014-03-31 1,058.57 65.03
2013-12-31 1,057.20 65.65
2013-09-30 1,020.25 65.54
2013-06-30 981.64 64.80
2013-03-31 952.47 64.43
2012-12-31 899.25 54.62
2012-09-30 901.14 60.00
2012-06-30 871.56 57.72
2012-03-31 828.76 54.34
2011-12-31 772.08 50.03

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Envision Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Envision Healthcare has efficiently used its assets last year compared to the DE Healthcare industry average (Return on Assets) as it is loss-making.
  • Envision Healthcare's use of capital has not improved over the past 3 years (Return on Capital Employed).
X
Past performance checks
We assess Envision Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Envision Healthcare has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Envision Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Envision Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Envision Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Envision Healthcare's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Envision Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Envision Healthcare Company Filings, last reported 3 months ago.

BST:N16 Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 5,467.40 4,626.60 593.50
2018-03-31 7,275.80 4,621.20 767.40
2017-12-31 7,356.50 6,315.40 312.20
2017-09-30 7,242.40 6,323.20 278.10
2017-06-30 7,222.20 6,329.40 441.30
2017-03-31 7,131.00 5,832.70 225.30
2016-12-31 7,570.80 5,836.80 316.90
2016-09-30 3,131.93 2,613.92 106.06
2016-06-30 3,037.98 2,601.82 74.11
2016-03-31 2,971.50 2,356.52 85.88
2015-12-31 2,940.40 2,378.40 106.70
2015-09-30 2,434.48 2,250.28 187.42
2015-06-30 2,405.76 2,249.46 126.29
2015-03-31 2,330.26 2,248.85 116.16
2014-12-31 2,282.33 2,251.01 208.08
2014-09-30 2,234.09 2,248.68 194.08
2014-06-30 1,360.16 577.00 44.91
2014-03-31 1,323.32 585.22 47.12
2013-12-31 1,303.25 604.14 50.84
2013-09-30 1,266.63 620.76 45.50
2013-06-30 1,218.57 616.04 39.92
2013-03-31 1,187.23 623.35 42.41
2012-12-31 1,175.85 638.11 46.40
2012-09-30 975.75 397.96 35.68
2012-06-30 955.72 419.74 37.65
2012-03-31 941.39 447.56 44.32
2011-12-31 919.10 458.76 47.23
  • Envision Healthcare's level of debt (84.6%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (50.5% vs 84.6% today).
  • Debt is not well covered by operating cash flow (9.6%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 3x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Envision Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Envision Healthcare has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Envision Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Envision Healthcare dividends.
If you bought €2,000 of Envision Healthcare shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Envision Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Envision Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:N16 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 13 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.2%
Germany Market Average Dividend Yield Market Cap Weighted Average of 332 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BST:N16 Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31
2019-12-31 0.00 1.00
2018-12-31 0.00 2.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Envision Healthcare has not reported any payouts.
  • Unable to verify if Envision Healthcare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Envision Healthcare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Envision Healthcare has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Envision Healthcare's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Envision Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Envision Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Envision Healthcare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Envision Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Christopher Holden, image provided by Google.
Christopher Holden
COMPENSATION $21,726,391
AGE 54
TENURE AS CEO 1.8 years
CEO Bio

Mr. Christopher A. Holden has been the Chief Executive Officer and President of Envision Healthcare Corporation (alternate name: AmSurg Corp.), headquartered in Nashville, Tennessee and Envision Healthcare Corporation, headquartered in Greenwood Village, Colorado since December 2016. Mr. Holden is a healthcare services industry veteran with more than 25 years of experience, having spent most of his career in multi-facility and multi-market healthcare management. Mr. Holden served as the Chief Executive Officer and President at Sheridan Healthcare, Inc. until December 5, 2016. He served as the Chief Executive Officer and President at Envision Healthcare Holdings, Inc. Mr. Holden served as the Chief Executive Officer and President of AmSurg Corp. since October 1, 2007 until 2016. Mr. Holden founded Triad Healthcare Corporation in 1999 and served as its Division President since May 29, 2001. From May 11, 1999 to May 29, 2001, he served as a Senior Vice President of Triad Hospitals Inc. From January 1, 1998 to May 11, 1999, he served as President of West Division of the Pacific Group of HCA Healthcare Corporation. Mr. Holden was a founding team member and officer at Triad Hospitals, Inc. since May 1999. Mr. Holden served as the President of West Texas Division of the Central Group of HCA from September 1997 to January 1, 1998 and Vice President of Administration for Central Group of HCA from August 1994 to September 1997. He served as an Assistant Vice President of Administration of Central Group of National Medical Enterprises, Inc., where he involved in hospital administration for five years. Mr. Holden is a healthcare industry veteran of more than 30 years, engaged during most of his career directly in multi-facility and multi-market healthcare management. From August 1994 to May 1999, he held several officer positions with Columbia/HCA Healthcare Corporation. He serves as Director At-Large at Nashville Health Care Council. He has been a Director of Envision Healthcare Corporation since December 2016. He serves as a Director of Sheridan Healthcare, Inc. He served as a Director at AmSurg Corp. since October 1, 2007. He served as a Director at Envision Healthcare Holdings, Inc. Mr. Holden received his Bachelor of Science degree in Health Policy and Administration from The University of North Carolina and his Juris Doctorate and Masters in Healthcare Administration degrees from Washington University in St. Louis.

CEO Compensation
  • Christopher's compensation has increased whilst company is loss making.
  • Christopher's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Envision Healthcare management team in years:

1
Average Tenure
53
Average Age
  • The average tenure for the Envision Healthcare management team is less than 2 years, this suggests a new team.
Management Team

Christopher Holden

TITLE
CEO, President & Director
COMPENSATION
$22M
AGE
54
TENURE
1.8 yrs

Kevin Eastridge

TITLE
Executive VP & CFO
COMPENSATION
$1M
AGE
53
TENURE
1 yrs

Karey Witty

TITLE
Executive VP & COO
AGE
53
TENURE
1 yrs

Kenneth Zongor

TITLE
Senior VP & Chief Accounting Officer
AGE
42
TENURE
1 yrs

Bob Kneeley

TITLE
Vice President of Investor Relations

Craig Wilson

TITLE
Senior VP
AGE
49
TENURE
2.8 yrs

Phillip Clendenin

TITLE
Executive VP & President of Ambulatory Services
COMPENSATION
$2M
AGE
53

Patrick Solomon

TITLE
Senior VP & Chief Strategy Officer
AGE
49
TENURE
2.8 yrs

Brian Jackson

TITLE
Executive VP & President of Physician Services
AGE
55
TENURE
1 yrs

John Clark

TITLE
Vice President of Development
Board of Directors Tenure

Average tenure and age of the Envision Healthcare board of directors in years:

2
Average Tenure
65
Average Age
  • The average tenure for the Envision Healthcare board of directors is less than 3 years, this suggests a new board.
Board of Directors

Bill Sanger

TITLE
Non-Executive Chairman of the Board
COMPENSATION
$7M
AGE
68
TENURE
1.8 yrs

Christopher Holden

TITLE
CEO, President & Director
COMPENSATION
$22M
AGE
54
TENURE
1.8 yrs

Jim Deal

TITLE
Independent Director
COMPENSATION
$294K
AGE
68
TENURE
2.8 yrs

Cindy Miller

TITLE
Independent Director
COMPENSATION
$286K
AGE
61
TENURE
2 yrs

Carol Burt

TITLE
Independent Director
COMPENSATION
$224K
AGE
60
TENURE
2.8 yrs

Mike Smith

TITLE
Independent Director
COMPENSATION
$298K
AGE
69
TENURE
2.8 yrs

Denny Shelton

TITLE
Lead Independent Director
COMPENSATION
$215K
AGE
65
TENURE
0.8 yrs

Steve Geringer

TITLE
Director
COMPENSATION
$363K
AGE
72
TENURE
2 yrs

Kevin Lavender

TITLE
Director
COMPENSATION
$283K
AGE
56
TENURE
2 yrs

Joey Jacobs

TITLE
Director
COMPENSATION
$250K
AGE
65
TENURE
2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Start End Shares Value (USD)
X
Management checks
We assess Envision Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Envision Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

External News
Loading...
Simply Wall St News

Company Info

Map
Description

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The company also offers ambulatory surgical centers (ASCs) services that provide surgical procedures across multiple specialties, including gastroenterology, ophthalmology, orthopedics, and others. It operated 264 ASCs in 35 states and the District of Columbia. In addition, it provides surgery services, such as management, oversight, and surgeon staffing for trauma surgery services; offers direct patient care and care coordination by clinicians outside the acute care setting through physician-led post-acute care services; and operates office-based medical practices that primarily focus on women’s health, as well as provides physician staffing and related management services. Further, it offers medical transportation services in 41 states and the District of Columbia. The company offers its clinical solutions for health systems, payors, providers, and patients. Envision Healthcare Corporation was founded in 1992 and is based in Nashville, Tennessee.

Details
Name: Envision Healthcare Corporation
N16
Exchange: BST
Founded: 1992
$4,782,461,776
119,913,707
Website: http://www.evhc.net
Address: Envision Healthcare Corporation
1A Burton Hills Boulevard,
Nashville,
Tennessee, 37215,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE EVHC Common Stock New York Stock Exchange US USD 13. Jul 2001
BST N16 Common Stock Boerse-Stuttgart DE EUR 13. Jul 2001
LSE 0IHZ Common Stock London Stock Exchange GB USD 13. Jul 2001
Number of employees
Current staff
Staff numbers
57,750
Envision Healthcare employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2018/10/11 18:46
End of day share price update: 2018/10/10 00:00
Last estimates confirmation: 2018/10/09
Last earnings filing: 2018/08/07
Last earnings reported: 2018/06/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.